FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/01/2026
Back to search
Official data from USPTO
CHASING CURES. DELIVERING HOPE.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CHASING CURES. DELIVERING HOPE.
ST13
US500000079397997Class
5, 10, 42
Filing
79397997
Registration
7797603
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 10, 42
Filing date
02/22/2024
Registration date
05/20/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/20/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
London, GB
Examiner
HUDSON, TAMARA BREE
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Aviadobio Ltd
Aviadobio Ltd
Representatives
Matthew J. Snider Dickinson Wright PLLC
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and biotechnological preparations and substances being pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; drug delivery agents consisting of compoundsliposomes and viral particles that facilitate delivery of a wide range of pharmaceuticals
Class 10
Medical instruments and apparatus for use in surgery; medical instruments and apparatusclamps for surgical usesurgical retractorssurgical platformssurgical stabilizerssurgical manipulator arms; medical diagnostic instruments and apparatus for the diagnosis of neurological diseases and disorderssold without medication; medical instruments and apparatus for administering pharmaceutical and biotechnological preparations and substancessold without medication; medical instruments and apparatus for administering pharmaceutical and biotechnological preparations and substances for the prevention and treatment of neurological diseases and disorderssold without medication; implantable drug delivery devicesimplantable drug delivery pumps and implantable drug delivery ports
Class 42
Scientific and technological servicesresearch and design in the fields of medicinehealthhealthcarewellbeingclinical trialspharmaceuticalsbiotechnologybiotechnological preparations and substancesgene therapyneurosurgerymedical imagingmedical and scientific instruments and apparatusneurologyneurologicalneuromuscular and neurodegenerative therapeuticsdiseases and disorders; design and development of computer hardware and software; scientific research and developmentbiological research and developmentclinical research and developmentmedical research and development; researchdevelopment and testing relating to pharmaceutical and biotechnological preparations and substances; researchdevelopment and testing relating to medical and scientific instruments and apparatus; researchdevelopment and testing relating to neurological therapeuticsdiseases and disorders; design and development of medical diagnostic apparatus; scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical and biotechnological preparations and substances; scientific research in the nature of conducting clinical trials for others in the fields of neurological therapeuticsdiseases and disorders; scientific research in the nature of conducting clinical trials for others in the fields of medical and scientific instruments and apparatus; providing onlinenon-downloadable software for use in developingtesting and administering pharmaceutical and biotechnological preparations and substances for the preventiondiagnosis and treatment of neurological and neuromuscular diseases and disorders; providing onlinenon-downloadable software for analysing clinical information; providing onlinenon-downloadable software for diagnosis of neurological diseases and disorders; providing onlinenon-downloadable software for operating medical instruments and apparatus; providing onlinenon-downloadable software for connecting machines and medical instruments and apparatus; providing onlinenon-downloadable software for collecting and exchanging information and data; providing onlinenon-downloadable software for monitoring medical instruments and apparatus and interfacing with the cloud; providing onlinenon-downloadable software for mobile devicessmartphonestablet computerspersonal computers and televisions for use in developingtesting and administering pharmaceutical and biotechnological preparations and substances for the prevention and treatment of neurological and neuromuscular diseases and disorders; providing onlinenon-downloadable software for transmittingsharingreceivingstreamingdownloadingplayingorganizingdisplayingcollecting and transferring informationdataaudiovideoimagescontent and other multimedia content between devices via the internetover a wireless network and other communications networks; providing onlinenon-downloadable software for the remote control of machines and medical instruments and apparatus; providing onlinenon-downloadable software for facilitating cloud computing services; information technology servicestechnical consulting services relating to the technology fields of medical and scientific instruments and apparatus; information technology servicestechnical consulting services relating to the technology fields of pharmaceutical and biotechnological preparations and substances; advisory and consulting services related to the aforegoing services
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/17/2025
FIMP
FINAL DISPOSITION PROCESSED
12/17/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/05/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/19/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/19/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/20/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/20/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/20/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2025
PUBO
PUBLISHED FOR OPPOSITION
04/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/26/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/10/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/10/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/10/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/14/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/14/2025
RFNT
REFUSAL PROCESSED BY IB
10/07/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/16/2024
RFRR
REFUSAL PROCESSED BY MPU
09/16/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/14/2024
CNRT
NON-FINAL ACTION WRITTEN
09/13/2024
DOCK
ASSIGNED TO EXAMINER
09/11/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/21/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/21/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/20/2024
Continuous trademark protection
Get notified about every new filing that threatens CHASING CURES. DELIVERING HOPE. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.